Similar Articles
Non-pharmacologic Approaches to Dysphagia in Patients with Multiple Sclerosis: A Systematic Review
Gülşah Kesik, Leyla Özdemir
DOI: 10.4274/tnd.2020.55770
The Predictive Value of the Systemic Immune-inflammation Index as a New Prognostic Marker for Disability in Patients with Multiple Sclerosis
Hikmet Saçmacı, Tülin Aktürk, Nermin Tanık
DOI: 10.4274/tnd.2021.50329
The Diagnostic and Prognostic Value of Magnetic Resonance Imaging for Evaluating Atypical Inflammatory Demyelinating Lesions
Zeynep Özdemir, Erkan Acar, Aysun Soysal
DOI: 10.4274/tnd.2021.00907
Investigation of the Effects of Game Supported Rehabilitation Program on Motor and Cognitive Skills in a Patient with Co-occurrence of Multiple Sclerosis and Parkinson’s Disease: A Case Report
Gülşah Sütçü, Muhammed Kılınç
DOI: 10.4274/tnd.2020.84594
Epilepsia Partialis Continua in a Patient with Progressive Multiple Sclerosis
Gökhan Görken, Abdullah Yılgör
DOI: 10.4274/tnd.2020.96992
Effects of Body Temperature Lowering on Visual Evoked Potentials in Patients with Multiple Sclerosis
Turan Poyraz, Fethi İdiman, Ahmet Onur Keskin, Leyla İyilikçi Karaoğlan, Egemen İdiman
DOI: 10.4274/tnd.2020.25589
Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities
Cem Bölük, Ülkü Türk Börü, Mustafa Taşdemir, Tuğçe Gezer
DOI: 10.4274/tnd.2020.36418
Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
Beuy Joob, Viroj Wowanitkit
DOI: 10.4274/tnd.2020.99897
Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability
Hatice Ayan, Özge Ertekin, Turhan Kahraman, Serkan Özakbaş
DOI: 10.4274/tnd.2020.36036
A Multifaceted Evaluation of National Off-label Neurology Applications
Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe
DOI: 10.4274/tnd.2020.37791
The Role of Neurologist in the Assessment and Treatment of Depression
Emre Kumral, Fatma Ece Bayam
DOI: 10.4274/tnd.2019.44341
Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak
DOI: 10.4274/tnd.2019.34392
Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy
DOI: 10.4274/tnd.2019.77010
The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu
DOI: 10.4274/tnd.2019.09735
Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler
DOI: 10.4274/tnd.2019.33341
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk
DOI: 10.4274/tnd.2019.93206
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
Bahar Say, Ufuk Ergün
DOI: 10.4274/tnd.2019.87513
Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes
İpek Güngör Doğan
DOI: 10.4274/tnd.2019.97720
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725